Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer.

Tesfay L, Paul BT, Hegde P, Brewer M, Habbani S, Jellison E, Moore T, Wu H, Torti SV, Torti FM
Sci Rep. 2022 Nov 19;12(1):19936. doi: 10.1038/s41598-022-24391-3. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.